Goldan Keith A. (CIK 1495411) reported 14 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-02). Recent activity: Sell SNDX (1,177 shares), Buy ABEO (32,751 shares), Sell SNDX (3,410 shares), Buy SNDX (1,219 shares), Buy SNDX (21,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Sell | 1,177 | $22,351 |
| 2026-04-07 | ABEONA THERAPEUTICS INC. (ABEO) | Director | Buy | 32,751 | $0 |
| 2026-02-10 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Sell | 3,410 | $71,712 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Buy | 1,219 | $10,337 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Buy | 21,500 | $0 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Buy | 30,750 | $0 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Sell | 2,082 | $42,931 |
| 2025-12-01 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Sell | 1,224 | $0 |
| 2025-08-07 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Buy | 1,226 | $10,335 |
| 2025-07-18 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Sell | 1,296 | $12,040 |
| 2025-05-19 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Buy | 3,000 | $0 |
| 2025-02-12 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Sell | 3,777 | $58,544 |
| 2025-02-07 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Buy | 18,500 | $0 |
| 2025-02-07 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | Buy | 23,400 | $0 |
Source: SEC Form 4 filings · as of 2026-06-02